Dysfunction of Respiratory Enzymes in Adults With Mental Illness (DREAM)

Summary

This study tested whether intravenous methylene blue changes brain activity during a working-memory task differently in adults with schizophrenia taking stable antipsychotic medication and healthy volunteers. Each participant received methylene blue and a placebo solution with no methylene blue at separate visits and completed the task during functional magnetic resonance imaging (fMRI)

Timeline

Start

2020-06-01

Primary completion

2025-08-31

Completion

2025-08-31

Drugs

Indications